Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial144

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial56

Views

Views
October 20253
November 20257
December 20254
January 202612
February 20260
March 202613
April 202617
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States26
Brazil7
Finland5
Tunisia3
United Kingdom2
Singapore2
France2
United Arab Emirates1
Angola1
Argentina1
 

Top cities views

Views
San Jose7
Ashburn7
Helsinki5
Campos dos Goytacazes2
Belo Horizonte1
Belém1
Calgary1
Cleveland1
Frankfurt am Main1
Iquique1